These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differences in lung bioavailability between different propellants for fluticasone propionate. Wilson AM; Sims EJ; Orr LC; Lipworth BJ Lancet; 1999 Oct; 354(9187):1357-8. PubMed ID: 10533870 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group. Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers. Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002 [TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Cripps A; Riebe M; Schulze M; Woodhouse R Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679 [TBL] [Abstract][Full Text] [Related]
7. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability. Brindley A J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978 [TBL] [Abstract][Full Text] [Related]
8. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers. Leach CL; Davidson PJ; Hasselquist BE; Boudreau RJ Chest; 2002 Aug; 122(2):510-6. PubMed ID: 12171824 [TBL] [Abstract][Full Text] [Related]
9. Budesonide administered using chlorofluorocarbon and hydrofluoroalkane pressurized metered-dose inhalers: pharmacokinetics, pharmacodynamics and clinical equivalence. Singh D; Tutuncu A; Lohr I; Carlholm M; Polanowski T Int J Clin Pharmacol Ther; 2007 Sep; 45(9):485-95. PubMed ID: 17907591 [TBL] [Abstract][Full Text] [Related]
10. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma. Kim KT; Milgrom H; Yoon YK; Levy AL; Matz P; Welch MJ; Cahn A; Collins DA; Kathman S; Mehta R; Su SF; Kunka RL J Clin Pharmacol; 2008 Jan; 48(1):108-16. PubMed ID: 18094223 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group. Perruchoud AP; Lundback B; Yigla M; Sykes AP Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group. Ayres JG; Millar AB; Sykes AP Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685 [TBL] [Abstract][Full Text] [Related]
15. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604 [TBL] [Abstract][Full Text] [Related]
16. Hydrofluoroalkane mandate in effect January 1, 2009: Switch from chlorofluorocarbon- to hydrofluoroalkane-propelled inhalers requires active transition. Peters S Clin Cornerstone; 2009; 9(3):50-3. PubMed ID: 19781516 [TBL] [Abstract][Full Text] [Related]